Chemical Elicitors Induce Rare Bioactive Secondary Metabolites in Deep-Sea Bacteria under Laboratory Conditions
Authors:
- Rafael de FelícioRFRafael de Felício
- Patricia BallonePBPatricia Ballone
- Cristina Freitas BazzanoCBCristina Freitas Bazzano
- Luiz F. G. AlvesLALuiz F. G. Alves
- Renata SigristRenata Sigrist
- Gina Polo InfanteGIGina Polo Infante
- Henrique NieroHNHenrique Niero
- Fernanda Rodrigues-CostaFRFernanda Rodrigues-Costa
- Arthur Zanetti Nunes FernandesArthur Zanetti Nunes Fernandes
- Luciane A. C. TononLTLuciane A. C. Tonon
- Luciana S. ParadelaLPLuciana S. Paradela
- Renna Karoline Eloi CostaRCRenna Karoline Eloi Costa
Open Access
- 12 February 2021
- journal article
- research article
- Published by MDPI AG in Metabolites
- Vol. 11 (2) , 107
Abstract
Bacterial genome sequencing has revealed a vast number of novel biosynthetic gene clusters (BGC) with potential to produce bioactive natural products. However, the biosynthesis of secondary metabolites by bacteria is often silenced under laboratory conditions, limiting the controlled expression of natural products. Here we describe an integrated methodology for the construction and screening of an elicited and pre-fractionated library of marine bacteria. In this pilot study, chemical elicitors were evaluated to mimic the natural environment and to induce the expression of cryptic BGCs in deep-sea bacteria. By integrating high-resolution untargeted metabolomics with cheminformatics analyses, it was possible to visualize, mine, identify and map the chemical and biological space of the elicited bacterial metabolites. The results show that elicited bacterial metabolites correspond to ~45% of the compounds produced under laboratory conditions. In addition, the elicited chemical space is novel (~70% of the elicited compounds) or concentrated in the chemical space of drugs. Fractionation of the crude extracts further evidenced minor compounds (~90% of the collection) and the detection of biological activity. This pilot work pinpoints strategies for constructing and evaluating chemically diverse bacterial natural product libraries towards the identification of novel bacterial metabolites in natural product-based drug discovery pipelines.Keywords
Funding Information
- Instituto Serrapilheira (Serra-1709-19681)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88882.143438/2017, 88882.435477/2019-01)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2014/10753-9, 2017/12436-9, 2015/19906-5)
This publication has 58 references indexed in Scilit:
- Draft Genome Sequence of Bacillus stratosphericus LAMA 585, Isolated from the Atlantic Deep SeaMicrobiology Resource Announcements, 2013
- Phylogenetic identification of marine bacteria isolated from deep-sea sediments of the eastern South Atlantic OceanSpringerPlus, 2013
- Bacterial Self-Resistance to the Natural Proteasome Inhibitor Salinosporamide AACS Chemical Biology, 2011
- Small‐molecule elicitation of microbial secondary metabolitesMicrobial Biotechnology, 2011
- Characterization of the lnmKLM Genes Unveiling Key Intermediates for β-Alkylation in Leinamycin BiosynthesisOrganic Letters, 2010
- Verticilactam, a New Macrolactam Isolated from a Microbial Metabolite Fraction LibraryOrganic Letters, 2010
- New developments in microbial interspecies signalingCurrent Opinion in Microbiology, 2009
- Pre-fractionated Microbial Samples – The Second Generation Natural Products Library at WyethMolecules, 2008
- Chemical space and biologyNature, 2004
- Salinosporamide A: A Highly Cytotoxic Proteasome Inhibitor from a Novel Microbial Source, a Marine Bacterium of the New Genus SalinosporaAngewandte Chemie International Edition, 2003